NASDAQ-GS · traded in Congress
Moderna, MRNA
$196.32 +1.50 (+0.77%) Sep 25, 2026 5:13 AM ET
Market value$78.4B
P/E ratio-
Analyst target$125.00
52-week range-
Avg volume18,217,100
Dividend yieldN/A
Chart
Congress trades in MRNA
Members of Congress disclosed 2 transactions in MRNA in the filings we have processed.
| Traded | Member | Type | Amount | Filed |
|---|---|---|---|---|
| 08/19/2026 | Maria Elvira Salazar FL27 | Partial sale | $1,001 - $15,000 | 9/9/2026 filing |
| 08/19/2026 | Maria Elvira Salazar FL27 | Purchase | $1,001 - $15,000 | 9/9/2026 filing |
Disclosed under the STOCK Act. Amounts are the ranges the law requires, filings can lag a trade by up to 45 days, and a disclosure is not evidence of wrongdoing. All congressional trades ›
Other companies
Price and key figures from Nasdaq's public quote data, refreshed through the day; the chart is live from TradingView. Congressional trades parsed from official House filings. Market information, not investment advice.